><title>References</title><ref id="pone.0070063-WHO1"><label>1</label><mixed-citation publication-type="other">WHO (2010) Global Tuberculosis Control Report.</mixed-citation></ref><ref id="pone.0070063-Dorhoi1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Dorhoi</surname><given-names>A</given-names></name>, <name><surname>Reece</surname><given-names>ST</given-names></name>, <name><surname>Kaufmann</surname><given-names>SH</given-names></name> (<year>2011</year>) <article-title>For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection</article-title>. <source>Immunol Rev</source>
<volume>240</volume>: <fpage>235</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">21349097</pub-id></mixed-citation></ref><ref id="pone.0070063-Frieden1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Frieden</surname><given-names>TR</given-names></name>, <name><surname>Sterling</surname><given-names>TR</given-names></name>, <name><surname>Munsiff</surname><given-names>SS</given-names></name>, <name><surname>Watt</surname><given-names>CJ</given-names></name>, <name><surname>Dye</surname><given-names>C</given-names></name> (<year>2003</year>) <article-title>Tuberculosis</article-title>. <source>Lancet</source>
<volume>362</volume>: <fpage>887</fpage>&#x02013;<lpage>899</lpage>.<pub-id pub-id-type="pmid">13678977</pub-id></mixed-citation></ref><ref id="pone.0070063-vanRie1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>van Rie</surname><given-names>A</given-names></name>, <name><surname>Warren</surname><given-names>R</given-names></name>, <name><surname>Richardson</surname><given-names>M</given-names></name>, <name><surname>Victor</surname><given-names>TC</given-names></name>, <name><surname>Gie</surname><given-names>RP</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment</article-title>. <source>N Engl J Med</source>
<volume>341</volume>: <fpage>1174</fpage>&#x02013;<lpage>1179</lpage>.<pub-id pub-id-type="pmid">10519895</pub-id></mixed-citation></ref><ref id="pone.0070063-Walzl1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Walzl</surname><given-names>G</given-names></name>, <name><surname>Ronacher</surname><given-names>K</given-names></name>, <name><surname>Djoba Siawaya</surname><given-names>JF</given-names></name>, <name><surname>Dockrell</surname><given-names>HM</given-names></name> (<year>2008</year>) <article-title>Biomarkers for TB treatment response: challenges and future strategies</article-title>. <source>J Infect</source>
<volume>57</volume>: <fpage>103</fpage>&#x02013;<lpage>109</lpage>.<pub-id pub-id-type="pmid">18649943</pub-id></mixed-citation></ref><ref id="pone.0070063-Walzl2"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Walzl</surname><given-names>G</given-names></name>, <name><surname>Ronacher</surname><given-names>K</given-names></name>, <name><surname>Hanekom</surname><given-names>W</given-names></name>, <name><surname>Scriba</surname><given-names>TJ</given-names></name>, <name><surname>Zumla</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>Immunological biomarkers of tuberculosis</article-title>. <source>Nat Rev Immunol</source>
<volume>11</volume>: <fpage>343</fpage>&#x02013;<lpage>354</lpage>.<pub-id pub-id-type="pmid">21475309</pub-id></mixed-citation></ref><ref id="pone.0070063-Wallis1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Wallis</surname><given-names>RS</given-names></name>, <name><surname>Wang</surname><given-names>C</given-names></name>, <name><surname>Doherty</surname><given-names>TM</given-names></name>, <name><surname>Onyebujoh</surname><given-names>P</given-names></name>, <name><surname>Vahedi</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Biomarkers for tuberculosis disease activity, cure, and relapse</article-title>. <source>Lancet Infect Dis</source>
<volume>10</volume>: <fpage>68</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">20113972</pub-id></mixed-citation></ref><ref id="pone.0070063-Nunn1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Nunn</surname><given-names>AJ</given-names></name>, <name><surname>Phillips</surname><given-names>PP</given-names></name>, <name><surname>Mitchison</surname><given-names>DA</given-names></name> (<year>2010</year>) <article-title>Timing of relapse in short-course chemotherapy trials for tuberculosis</article-title>. <source>Int J Tuberc Lung Dis</source>
<volume>14</volume>: <fpage>241</fpage>&#x02013;<lpage>242</lpage>.<pub-id pub-id-type="pmid">20074418</pub-id></mixed-citation></ref><ref id="pone.0070063-Woodworth1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Woodworth</surname><given-names>JS</given-names></name>, <name><surname>Behar</surname><given-names>SM</given-names></name> (<year>2006</year>) <article-title>Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity</article-title>. <source>Crit Rev Immunol</source>
<volume>26</volume>: <fpage>317</fpage>&#x02013;<lpage>352</lpage>.<pub-id pub-id-type="pmid">17073557</pub-id></mixed-citation></ref><ref id="pone.0070063-Winslow1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Winslow</surname><given-names>GM</given-names></name>, <name><surname>Cooper</surname><given-names>A</given-names></name>, <name><surname>Reiley</surname><given-names>W</given-names></name>, <name><surname>Chatterjee</surname><given-names>M</given-names></name>, <name><surname>Woodland</surname><given-names>DL</given-names></name> (<year>2008</year>) <article-title>Early T-cell responses in tuberculosis immunity</article-title>. <source>Immunol Rev</source>
<volume>225</volume>: <fpage>284</fpage>&#x02013;<lpage>299</lpage>.<pub-id pub-id-type="pmid">18837789</pub-id></mixed-citation></ref><ref id="pone.0070063-Smith1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Smith</surname><given-names>SM</given-names></name>, <name><surname>Brookes</surname><given-names>R</given-names></name>, <name><surname>Klein</surname><given-names>MR</given-names></name>, <name><surname>Malin</surname><given-names>AS</given-names></name>, <name><surname>Lukey</surname><given-names>PT</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A</article-title>. <source>J Immunol</source>
<volume>165</volume>: <fpage>7088</fpage>&#x02013;<lpage>7095</lpage>.<pub-id pub-id-type="pmid">11120838</pub-id></mixed-citation></ref><ref id="pone.0070063-Kamath1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Kamath</surname><given-names>AB</given-names></name>, <name><surname>Woodworth</surname><given-names>J</given-names></name>, <name><surname>Xiong</surname><given-names>X</given-names></name>, <name><surname>Taylor</surname><given-names>C</given-names></name>, <name><surname>Weng</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection</article-title>. <source>J Exp Med</source>
<volume>200</volume>: <fpage>1479</fpage>&#x02013;<lpage>1489</lpage>.<pub-id pub-id-type="pmid">15557351</pub-id></mixed-citation></ref><ref id="pone.0070063-Serbina1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Serbina</surname><given-names>NV</given-names></name>, <name><surname>Flynn</surname><given-names>JL</given-names></name> (<year>1999</year>) <article-title>Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice</article-title>. <source>Infect Immun</source>
<volume>67</volume>: <fpage>3980</fpage>&#x02013;<lpage>3988</lpage>.<pub-id pub-id-type="pmid">10417164</pub-id></mixed-citation></ref><ref id="pone.0070063-Kamath2"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Kamath</surname><given-names>A</given-names></name>, <name><surname>Woodworth</surname><given-names>JS</given-names></name>, <name><surname>Behar</surname><given-names>SM</given-names></name> (<year>2006</year>) <article-title>Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection</article-title>. <source>J Immunol</source>
<volume>177</volume>: <fpage>6361</fpage>&#x02013;<lpage>6369</lpage>.<pub-id pub-id-type="pmid">17056567</pub-id></mixed-citation></ref><ref id="pone.0070063-Canaday1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Canaday</surname><given-names>DH</given-names></name>, <name><surname>Wilkinson</surname><given-names>RJ</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Harding</surname><given-names>CV</given-names></name>, <name><surname>Silver</surname><given-names>RF</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism</article-title>. <source>J Immunol</source>
<volume>167</volume>: <fpage>2734</fpage>&#x02013;<lpage>2742</lpage>.<pub-id pub-id-type="pmid">11509617</pub-id></mixed-citation></ref><ref id="pone.0070063-Stegelmann1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Stegelmann</surname><given-names>F</given-names></name>, <name><surname>Bastian</surname><given-names>M</given-names></name>, <name><surname>Swoboda</surname><given-names>K</given-names></name>, <name><surname>Bhat</surname><given-names>R</given-names></name>, <name><surname>Kiessler</surname><given-names>V</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Coordinate Expression of CC Chemokine Ligand 5, Granulysin, and Perforin in CD8+ T Cells Provides a Host Defense Mechanism against Mycobacterium tuberculosis</article-title>. <source>J Immunol</source>
<volume>175</volume>: <fpage>7474</fpage>&#x02013;<lpage>7483</lpage>.<pub-id pub-id-type="pmid">16301655</pub-id></mixed-citation></ref><ref id="pone.0070063-Sud1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Sud</surname><given-names>D</given-names></name>, <name><surname>Bigbee</surname><given-names>C</given-names></name>, <name><surname>Flynn</surname><given-names>JL</given-names></name>, <name><surname>Kirschner</surname><given-names>DE</given-names></name> (<year>2006</year>) <article-title>Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection</article-title>. <source>J Immunol</source>
<volume>176</volume>: <fpage>4296</fpage>&#x02013;<lpage>4314</lpage>.<pub-id pub-id-type="pmid">16547267</pub-id></mixed-citation></ref><ref id="pone.0070063-Obeidy1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Obeidy</surname><given-names>P</given-names></name>, <name><surname>Sharland</surname><given-names>AF</given-names></name> (<year>2009</year>) <article-title>NKG2D and its ligands</article-title>. <source>Int J Biochem Cell Biol</source>
<volume>41</volume>: <fpage>2364</fpage>&#x02013;<lpage>2367</lpage>.<pub-id pub-id-type="pmid">19631280</pub-id></mixed-citation></ref><ref id="pone.0070063-Burgess1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Burgess</surname><given-names>SJ</given-names></name>, <name><surname>Maasho</surname><given-names>K</given-names></name>, <name><surname>Masilamani</surname><given-names>M</given-names></name>, <name><surname>Narayanan</surname><given-names>S</given-names></name>, <name><surname>Borrego</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The NKG2D receptor: immunobiology and clinical implications</article-title>. <source>Immunol Res</source>
<volume>40</volume>: <fpage>18</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">18193361</pub-id></mixed-citation></ref><ref id="pone.0070063-Champsaur1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Champsaur</surname><given-names>M</given-names></name>, <name><surname>Lanier</surname><given-names>LL</given-names></name> (<year>2010</year>) <article-title>Effect of NKG2D ligand expression on host immune responses</article-title>. <source>Immunol Rev</source>
<volume>235</volume>: <fpage>267</fpage>&#x02013;<lpage>285</lpage>.<pub-id pub-id-type="pmid">20536569</pub-id></mixed-citation></ref><ref id="pone.0070063-Raulet1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Raulet</surname><given-names>DH</given-names></name> (<year>2003</year>) <article-title>Roles of the NKG2D immunoreceptor and its ligands</article-title>. <source>Nat Rev Immunol</source>
<volume>3</volume>: <fpage>781</fpage>&#x02013;<lpage>790</lpage>.<pub-id pub-id-type="pmid">14523385</pub-id></mixed-citation></ref><ref id="pone.0070063-Upshaw1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Upshaw</surname><given-names>JL</given-names></name>, <name><surname>Leibson</surname><given-names>PJ</given-names></name> (<year>2006</year>) <article-title>NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes</article-title>. <source>Semin Immunol</source>
<volume>18</volume>: <fpage>167</fpage>&#x02013;<lpage>175</lpage>.<pub-id pub-id-type="pmid">16723257</pub-id></mixed-citation></ref><ref id="pone.0070063-Das1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Das</surname><given-names>H</given-names></name>, <name><surname>Groh</surname><given-names>V</given-names></name>, <name><surname>Kuijl</surname><given-names>C</given-names></name>, <name><surname>Sugita</surname><given-names>M</given-names></name>, <name><surname>Morita</surname><given-names>CT</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function</article-title>. <source>Immunity</source>
<volume>15</volume>: <fpage>83</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">11485740</pub-id></mixed-citation></ref><ref id="pone.0070063-Karimi1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Karimi</surname><given-names>M</given-names></name>, <name><surname>Cao</surname><given-names>TM</given-names></name>, <name><surname>Baker</surname><given-names>JA</given-names></name>, <name><surname>Verneris</surname><given-names>MR</given-names></name>, <name><surname>Soares</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells</article-title>. <source>J Immunol</source>
<volume>175</volume>: <fpage>7819</fpage>&#x02013;<lpage>7828</lpage>.<pub-id pub-id-type="pmid">16339517</pub-id></mixed-citation></ref><ref id="pone.0070063-Markiewicz1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Markiewicz</surname><given-names>MA</given-names></name>, <name><surname>Carayannopoulos</surname><given-names>LN</given-names></name>, <name><surname>Naidenko</surname><given-names>OV</given-names></name>, <name><surname>Matsui</surname><given-names>K</given-names></name>, <name><surname>Burack</surname><given-names>WR</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation</article-title>. <source>J Immunol</source>
<volume>175</volume>: <fpage>2825</fpage>&#x02013;<lpage>2833</lpage>.<pub-id pub-id-type="pmid">16116168</pub-id></mixed-citation></ref><ref id="pone.0070063-Rajasekaran1"><label>26</label><mixed-citation publication-type="other">Rajasekaran K, Xiong V, Fong L, Gorski J, Malarkannan S (2010) Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells. PLoS One 5.</mixed-citation></ref><ref id="pone.0070063-Groh1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Groh</surname><given-names>V</given-names></name>, <name><surname>Rhinehart</surname><given-names>R</given-names></name>, <name><surname>Randolph-Habecker</surname><given-names>J</given-names></name>, <name><surname>Topp</surname><given-names>MS</given-names></name>, <name><surname>Riddell</surname><given-names>SR</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells</article-title>. <source>Nat Immunol</source>
<volume>2</volume>: <fpage>255</fpage>&#x02013;<lpage>260</lpage>.<pub-id pub-id-type="pmid">11224526</pub-id></mixed-citation></ref><ref id="pone.0070063-Diefenbach1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Diefenbach</surname><given-names>A</given-names></name>, <name><surname>Tomasello</surname><given-names>E</given-names></name>, <name><surname>Lucas</surname><given-names>M</given-names></name>, <name><surname>Jamieson</surname><given-names>AM</given-names></name>, <name><surname>Hsia</surname><given-names>JK</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D</article-title>. <source>Nat Immunol</source>
<volume>3</volume>: <fpage>1142</fpage>&#x02013;<lpage>1149</lpage>.<pub-id pub-id-type="pmid">12426565</pub-id></mixed-citation></ref><ref id="pone.0070063-Ehrlich1"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Ehrlich</surname><given-names>LI</given-names></name>, <name><surname>Ogasawara</surname><given-names>K</given-names></name>, <name><surname>Hamerman</surname><given-names>JA</given-names></name>, <name><surname>Takaki</surname><given-names>R</given-names></name>, <name><surname>Zingoni</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells</article-title>. <source>J Immunol</source>
<volume>174</volume>: <fpage>1922</fpage>&#x02013;<lpage>1931</lpage>.<pub-id pub-id-type="pmid">15699119</pub-id></mixed-citation></ref><ref id="pone.0070063-Rausch1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Rausch</surname><given-names>A</given-names></name>, <name><surname>Hessmann</surname><given-names>M</given-names></name>, <name><surname>Holscher</surname><given-names>A</given-names></name>, <name><surname>Schreiber</surname><given-names>T</given-names></name>, <name><surname>Bulfone-Paus</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells</article-title>. <source>Eur J Immunol</source>
<volume>36</volume>: <fpage>1156</fpage>&#x02013;<lpage>1167</lpage>.<pub-id pub-id-type="pmid">16619285</pub-id></mixed-citation></ref><ref id="pone.0070063-Cliff1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Cliff</surname><given-names>JM</given-names></name>, <name><surname>Andrade</surname><given-names>IN</given-names></name>, <name><surname>Mistry</surname><given-names>R</given-names></name>, <name><surname>Clayton</surname><given-names>CL</given-names></name>, <name><surname>Lennon</surname><given-names>MG</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Differential gene expression identifies novel markers of CD4+ and CD8+ T cell activation following stimulation by Mycobacterium tuberculosis</article-title>. <source>J Immunol</source>
<volume>173</volume>: <fpage>485</fpage>&#x02013;<lpage>493</lpage>.<pub-id pub-id-type="pmid">15210809</pub-id></mixed-citation></ref><ref id="pone.0070063-Burton1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Burton</surname><given-names>MJ</given-names></name>, <name><surname>Bailey</surname><given-names>RL</given-names></name>, <name><surname>Jeffries</surname><given-names>D</given-names></name>, <name><surname>Mabey</surname><given-names>DC</given-names></name>, <name><surname>Holland</surname><given-names>MJ</given-names></name> (<year>2004</year>) <article-title>Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic</article-title>. <source>Infect Immun</source>
<volume>72</volume>: <fpage>7352</fpage>&#x02013;<lpage>7356</lpage>.<pub-id pub-id-type="pmid">15557667</pub-id></mixed-citation></ref><ref id="pone.0070063-Rozen1"><label>33</label><mixed-citation publication-type="other">Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, S M, editors. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press,. 365&#x02013;386.</mixed-citation></ref><ref id="pone.0070063-Altschul1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Altschul</surname><given-names>SF</given-names></name>, <name><surname>Gish</surname><given-names>W</given-names></name>, <name><surname>Miller</surname><given-names>W</given-names></name>, <name><surname>Myers</surname><given-names>EW</given-names></name>, <name><surname>Lipman</surname><given-names>DJ</given-names></name> (<year>1990</year>) <article-title>Basic local alignment search tool</article-title>. <source>J Mol Biol</source>
<volume>215</volume>: <fpage>403</fpage>&#x02013;<lpage>410</lpage>.<pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation></ref><ref id="pone.0070063-Roberts1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Roberts</surname><given-names>AI</given-names></name>, <name><surname>Lee</surname><given-names>L</given-names></name>, <name><surname>Schwarz</surname><given-names>E</given-names></name>, <name><surname>Groh</surname><given-names>V</given-names></name>, <name><surname>Spies</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment</article-title>. <source>J Immunol</source>
<volume>167</volume>: <fpage>5527</fpage>&#x02013;<lpage>5530</lpage>.<pub-id pub-id-type="pmid">11698420</pub-id></mixed-citation></ref><ref id="pone.0070063-Maasho1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Maasho</surname><given-names>K</given-names></name>, <name><surname>Opoku-Anane</surname><given-names>J</given-names></name>, <name><surname>Marusina</surname><given-names>AI</given-names></name>, <name><surname>Coligan</surname><given-names>JE</given-names></name>, <name><surname>Borrego</surname><given-names>F</given-names></name> (<year>2005</year>) <article-title>NKG2D is a costimulatory receptor for human naive CD8+ T cells</article-title>. <source>J Immunol</source>
<volume>174</volume>: <fpage>4480</fpage>&#x02013;<lpage>4484</lpage>.<pub-id pub-id-type="pmid">15814668</pub-id></mixed-citation></ref><ref id="pone.0070063-Park1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Park</surname><given-names>YP</given-names></name>, <name><surname>Choi</surname><given-names>SC</given-names></name>, <name><surname>Kiesler</surname><given-names>P</given-names></name>, <name><surname>Gil-Krzewska</surname><given-names>A</given-names></name>, <name><surname>Borrego</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the gammac cytokines and TGF-beta1</article-title>. <source>Blood</source>
<volume>118</volume>: <fpage>3019</fpage>&#x02013;<lpage>3027</lpage>.<pub-id pub-id-type="pmid">21816829</pub-id></mixed-citation></ref><ref id="pone.0070063-Caccamo1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Caccamo</surname><given-names>N</given-names></name>, <name><surname>Guggino</surname><given-names>G</given-names></name>, <name><surname>Meraviglia</surname><given-names>S</given-names></name>, <name><surname>Gelsomino</surname><given-names>G</given-names></name>, <name><surname>Di Carlo</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection</article-title>. <source>PLoS One</source>
<volume>4</volume>: <fpage>e5528</fpage>.<pub-id pub-id-type="pmid">19436760</pub-id></mixed-citation></ref><ref id="pone.0070063-Berry1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Berry</surname><given-names>MP</given-names></name>, <name><surname>Graham</surname><given-names>CM</given-names></name>, <name><surname>McNab</surname><given-names>FW</given-names></name>, <name><surname>Xu</surname><given-names>Z</given-names></name>, <name><surname>Bloch</surname><given-names>SA</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source>
<volume>466</volume>: <fpage>973</fpage>&#x02013;<lpage>977</lpage>.<pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="pone.0070063-Cliff2"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Cliff</surname><given-names>JM</given-names></name>, <name><surname>Lee</surname><given-names>JS</given-names></name>, <name><surname>Constantinou</surname><given-names>N</given-names></name>, <name><surname>Cho</surname><given-names>JE</given-names></name>, <name><surname>Clark</surname><given-names>TG</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response</article-title>. <source>J Infect Dis</source>
<volume>207</volume>: <fpage>18</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">22872737</pub-id></mixed-citation></ref><ref id="pone.0070063-Parasa1"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Parasa</surname><given-names>VR</given-names></name>, <name><surname>Sikhamani</surname><given-names>R</given-names></name>, <name><surname>Raja</surname><given-names>A</given-names></name> (<year>2012</year>) <article-title>Effect of recombinant cytokines on the expression of natural killer cell receptors from patients with TB or/and HIV infection</article-title>. <source>PLoS One</source>
<volume>7</volume>: <fpage>e37448</fpage>.<pub-id pub-id-type="pmid">22715368</pub-id></mixed-citation></ref><ref id="pone.0070063-Hessmann1"><label>42</label><mixed-citation publication-type="other">Hessmann M, Rausch A, Ruckerl D, Adams PS, Simon M, <etal>et al</etal>.. (2010) DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection. Immunobiology.</mixed-citation></ref><ref id="pone.0070063-Hirsch1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Hirsch</surname><given-names>CS</given-names></name>, <name><surname>Hussain</surname><given-names>R</given-names></name>, <name><surname>Toossi</surname><given-names>Z</given-names></name>, <name><surname>Dawood</surname><given-names>G</given-names></name>, <name><surname>Shahid</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>93</volume>: <fpage>3193</fpage>&#x02013;<lpage>3198</lpage>.<pub-id pub-id-type="pmid">8622912</pub-id></mixed-citation></ref><ref id="pone.0070063-Olobo1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Olobo</surname><given-names>JO</given-names></name>, <name><surname>Geletu</surname><given-names>M</given-names></name>, <name><surname>Demissie</surname><given-names>A</given-names></name>, <name><surname>Eguale</surname><given-names>T</given-names></name>, <name><surname>Hiwot</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts</article-title>. <source>Scand J Immunol</source>
<volume>53</volume>: <fpage>85</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">11169211</pub-id></mixed-citation></ref><ref id="pone.0070063-Eisele1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Eisele</surname><given-names>G</given-names></name>, <name><surname>Wischhusen</surname><given-names>J</given-names></name>, <name><surname>Mittelbronn</surname><given-names>M</given-names></name>, <name><surname>Meyermann</surname><given-names>R</given-names></name>, <name><surname>Waldhauer</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells</article-title>. <source>Brain</source>
<volume>129</volume>: <fpage>2416</fpage>&#x02013;<lpage>2425</lpage>.<pub-id pub-id-type="pmid">16891318</pub-id></mixed-citation></ref><ref id="pone.0070063-Friese1"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Friese</surname><given-names>MA</given-names></name>, <name><surname>Wischhusen</surname><given-names>J</given-names></name>, <name><surname>Wick</surname><given-names>W</given-names></name>, <name><surname>Weiler</surname><given-names>M</given-names></name>, <name><surname>Eisele</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo</article-title>. <source>Cancer Res</source>
<volume>64</volume>: <fpage>7596</fpage>&#x02013;<lpage>7603</lpage>.<pub-id pub-id-type="pmid">15492287</pub-id></mixed-citation></ref><ref id="pone.0070063-Kloss1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Kloss</surname><given-names>M</given-names></name>, <name><surname>Decker</surname><given-names>P</given-names></name>, <name><surname>Baltz</surname><given-names>KM</given-names></name>, <name><surname>Baessler</surname><given-names>T</given-names></name>, <name><surname>Jung</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA</article-title>. <source>J Immunol</source>
<volume>181</volume>: <fpage>6711</fpage>&#x02013;<lpage>6719</lpage>.<pub-id pub-id-type="pmid">18981088</pub-id></mixed-citation></ref><ref id="pone.0070063-Vankayalapati1"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Vankayalapati</surname><given-names>R</given-names></name>, <name><surname>Garg</surname><given-names>A</given-names></name>, <name><surname>Porgador</surname><given-names>A</given-names></name>, <name><surname>Griffith</surname><given-names>DE</given-names></name>, <name><surname>Klucar</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium</article-title>. <source>J Immunol</source>
<volume>175</volume>: <fpage>4611</fpage>&#x02013;<lpage>4617</lpage>.<pub-id pub-id-type="pmid">16177106</pub-id></mixed-citation></ref><ref id="pone.0070063-Chalupny1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Chalupny</surname><given-names>NJ</given-names></name>, <name><surname>Rein-Weston</surname><given-names>A</given-names></name>, <name><surname>Dosch</surname><given-names>S</given-names></name>, <name><surname>Cosman</surname><given-names>D</given-names></name> (<year>2006</year>) <article-title>Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>346</volume>: <fpage>175</fpage>&#x02013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">16750166</pub-id></mixed-citation></ref><ref id="pone.0070063-Cerboni1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Cerboni</surname><given-names>C</given-names></name>, <name><surname>Ardolino</surname><given-names>M</given-names></name>, <name><surname>Santoni</surname><given-names>A</given-names></name>, <name><surname>Zingoni</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells</article-title>. <source>Blood</source>
<volume>113</volume>: <fpage>2955</fpage>&#x02013;<lpage>2964</lpage>.<pub-id pub-id-type="pmid">19124832</pub-id></mixed-citation></ref></